Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer

scientific article published on 27 April 2010

Characterization of FDG-PET images after stereotactic body radiation therapy for lung cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RADONC.2010.04.011
P698PubMed publication ID20430463
P5875ResearchGate publication ID43354419

P50authorYukinori MatsuoQ42321855
Kaori TogashiQ89794266
Yuji NakamotoQ91456447
P2093author name stringTatsuya Higashi
Tsuneo Saga
Masahiro Hiraoka
Kenji Takayama
Takashi Mizowaki
Keiko Shibuya
Yasushi Nagata
Masaru Narabayashi
Yoshiki Norihisa
P433issue2
P921main subjectadaptive radiation therapyQ180507
lung cancerQ47912
Fluorodeoxyglucose Positron Emission TomographyQ130273243
P304page(s)200-204
P577publication date2010-04-27
P1433published inRadiotherapy and OncologyQ14251029
P1476titleCharacterization of FDG-PET images after stereotactic body radiation therapy for lung cancer
P478volume97

Reverse relations

cites work (P2860)
Q64376629Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study
Q36241457Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
Q35990998Computed tomographic features predictive of local recurrence in patients with early stage lung cancer treated with stereotactic body radiation therapy
Q45070442Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings
Q36705231Illustrative cases of false positive biopsies after stereotactic body radiation therapy for lung cancer based on abnormal FDG-PET-CT imaging
Q37866792Imaging changes after stereotactic body radiation therapy for lung and liver tumors
Q34762759Interfractional variations of tumor centroid position and tumor regression during stereotactic body radiotherapy for lung tumor
Q64251198Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases
Q37643555Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography
Q37670432New techniques for assessing response after hypofractionated radiotherapy for lung cancer
Q36327908Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer
Q38849150Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?
Q51644443Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases.
Q36341962Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non-small cell lung cancer
Q92247615SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer
Q38161371Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team
Q35667829Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies
Q36230657Sublobar resection is associated with improved outcomes over radiotherapy in the management of high-risk elderly patients with Stage I non-small cell lung cancer: a systematic review and meta-analysis.
Q55441727[Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer].

Search more.